Skip to main content
Georgia Public Broadcasting Logo
  • Watch

    Featured Specials and Programs

    • All Creatures Great and Small
    • Antiques Roadshow
    • PBS News Hour
    • Miss Scarlet & The Duke
    • Finding Your Roots
    • Doc Martin
    All Programs

    GPB Originals

    • Georgia Legends
    • Lawmakers
    • A Fork in the Road
    • View Finders
    • Georgia Outdoors
    • Your Fantastic Mind
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Listen

    Featured Programs

    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Narrative Edge
    • Peach Jam Podcast
    • A Fork in the Road
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Ways to Listen
    • Contact GPB
    • Newsletters
  • Learn

    Featured

    • Chemistry Matters
    • Classroom Conversations Podcast
    • GASHA Go! World
    • Georgia Farmcraft®
    • Georgia Classroom
    • Georgia Studies Collection
    • Econ Express
    • Let’s Go Enviro
    • Let's Learn GA!
    • Lights, Camera, Budget!
    • Live Explorations
    • Physics in Motion
    • School Stories
    • Virtual Field Trips
    • VR in the Classroom
    • Writers Contest

    For Kids & Teachers

    • GPB Games
    • PBS KIDS
    • PBS LearningMedia

    • on Twitter
    • on Facebook
    • on Email
  • News

    Featured Programs & Series

    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Narrative Edge

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Podcasts
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Heads Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Families

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Families Blog
    • Kids & Families Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Politics
  • Lawmakers
  • Elections

Don't Miss

Don't Miss:

  • Federal Funding Update
  • Caregiving program & Resources
  • Explore GPB Passport

News Articles: FDA

Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005.

Tagged as: 

  • Medical Treatments

A popular nasal decongestant doesn't actually relieve congestion, FDA advisers say

The FDA asked advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient were moved behind pharmacy counters.

September 12, 2023
|
By:
  • The Associated Press
Another round of COVID-19 vaccines is on the way. The Food and Drug Administration approved vaccines from Pfizer and Moderna that target an omicron subvariant called XBB.1.5. Vaccination campaigns, like this one in San Rafael, Calif., in 2022, could resume soon.

Tagged as: 

  • Health

New COVID vaccines get FDA approval

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

September 11, 2023
|
By:
  • Rob Stein
Lab data suggests the new COVID-19  booster shots should protect against a variant that concerns scientists. The boosters should be widely available this fall at pharmacies, like the one seen in the Flatbush neighborhood of Brooklyn borough in New York City.

Tagged as: 

  • Health

Lab data suggests new COVID booster will protect against worrisome variant

Preliminary laboratory studies find antibodies from previous infections and vaccinations can neutralize the BA.2.86 variant. The findings bode well for new boosters on the way this fall.

September 06, 2023
|
By:
  • Rob Stein
A pregnant woman stands for a portrait in Dallas on May 18. U.S. health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.

Tagged as: 

  • Health

The FDA approves the first pill specifically intended to treat postpartum depression

The Food and Drug Administration granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.

August 05, 2023
|
By:
  • The Associated Press
Disposable vapes in many kid-friendly fruity flavors, are displayed for sale at a shop in Pinecrest, Fla., Monday, June 26, 2023. Since 2020, the number of different vaping devices for sale in the U.S. has exploded, driven by a wave of disposable models from China.

Tagged as: 

  • Health

They're illegal. So why is it so easy to buy the disposable vapes favored by teens?

The FDA cracked down on the nicotine devices, yet they're stocked on many store shelves. The reason has to do with burgeoning overseas production, lack of clear rules, and lax enforcement.

July 14, 2023
|
By:
  • Yuki Noguchi
Prime energy drinks are displayed for sale on shelves at a Walmart Supercenter on July 10, 2023 in Austin, Texas. U.S. Sen. Chuck Schumer has called on the FDA to investigate whether the drinks pose health risks to children.

Tagged as: 

  • National

What to know about Prime, the Logan Paul drink that Sen. Schumer wants investigated

Prime drinks have become a Gen Z status symbol, a prized social media prop for a certain brand of teen male. But they're causing jitters among pediatricians who say they pack scary caffeine levels.

July 11, 2023
|
By:
  • Emily Olson
The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015.

Tagged as: 

  • Health

FDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the U.S.

The warning from the Food and Drug Administration is the latest attempt by regulators to crack down on illegal disposable vapes that have poured into U.S. stores in recent years.

June 23, 2023
|
By:
  • The Associated Press
The Food and Drug Administration approved the first gene therapy to treat the most common form of muscular dystrophy.

Tagged as: 

  • Health

Muscular dystrophy patients get first gene therapy

The Food and Drug Administration approved the first gene therapy for Duchenne muscular dystrophy, but limited access to those ages four and five.

June 22, 2023
|
By:
  • Rob Stein
Protesters filled the street in front of the Supreme Court after the court's decision to overturn <em>Roe v. Wade</em> on June 24, 2022. Nearly a year later, <em></em>61% of respondents to a new Gallup poll said overturning <em>Roe </em>was a "bad thing."

Tagged as: 

  • National

Nearly a year later, most Americans oppose Supreme Court's decision overturning Roe

The latest Gallup poll also finds increased political polarization. Some 60% of Democrats said abortion should be legal under any circumstances, compared with 8% of Republicans.

June 14, 2023
|
By:
  • Sarah McCammon
The first vaccine to protect infants from respiratory syncytial virus, or RSV, moved a step toward approval by the Food and Drug Administration with positive votes Thursday from a panel of experts.

Tagged as: 

  • Health

FDA advisers support approval of RSV vaccine to protect infants

At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.

May 18, 2023
|
By:
  • Scott Hensley and
  • Rob Stein
In a close vote, advisers to the Food and Drug Administration recommended approval of a gene therapy for muscular dystrophy developed by Sarepta Therapeutics.

Tagged as: 

  • Health

FDA advisers narrowly back first gene therapy for muscular dystrophy

A panel of experts voted 8-6 in favor of Food and Drug Administration approval of the first gene therapy for Duchenne muscular dystrophy, a fatal genetic disease.

May 12, 2023
|
By:
  • Scott Hensley and
  • Rob Stein
The U.S. is moving to ease restrictions on blood donations from gay and bisexual men and other groups that traditionally face higher risks of HIV. Here, tubes direct blood from a donor into a bag in Davenport, Iowa, on Friday, Nov. 11, 2022.

Tagged as: 

  • Health

More gay and bisexual men will now be able to donate blood under finalized FDA rules

While the number of people eligible to donate blood has expanded, the agency says it will continue to monitor the safety of the blood supply.

May 11, 2023
|
By:
  • Jonathan Franklin
An advisory panel to the Food and Drug Administration supported drugmaker Perrigo's application to sell the oral contraceptive Opill without a prescription.

Tagged as: 

  • Health

Advisers to the FDA back first over-the-counter birth control pill

In a unanimous vote, 17-0, a panel of advisers to the Food and Drug Administration recommended that the agency approve the first over-the-counter birth control pill.

May 11, 2023
|
By:
  • Scott Hensley and
  • Rob Stein
Advisers to the Food and Drug Administration will make a recommendation about whether the agency should approve the first over-the-counter birth control pill in the U.S.

Tagged as: 

  • Health

The FDA considers first birth control pill without a prescription

The Food and Drug Administration is weighing whether to allow a birth control pill to be sold over the counter for the first time. An advisory committee opens a two-day hearing Tuesday.

May 09, 2023
|
By:
  • Rob Stein
A closeup of a person's nose, mouth and hand while smoking a cigarette

Tagged as: 

  • Health

Menthol cigarettes disproportionately harm Black people. Why hasn't the FDA enacted a proposed ban?

A recent report finds that banning menthol and flavored cigarettes would eliminate disparities in lung cancer death rates between Black Americans and other racial groups within the next five years.

April 24, 2023
|
By:
  • Ellen Eldridge
  • Load More

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • Watch
  • Listen
  • Learn
  • News
  • Sports
  • Events
  • Kids & Families
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records and Document Retention Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2025, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®